1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide

1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide Struktur
1311465-22-1
CAS-Nr.
1311465-22-1
Englisch Name:
1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide
Synonyma:
1,3-diphenylimidazo[4,5-b]pyrazin-3-ium;1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide;1H-lmidazo[4,5-b]pyrazinium,1,3-diphenyl-,iodide;1,3-Diphenyl-1H-imidazo[4,5-b]pyrazin-3-ium iodide
CBNumber:
CB06223207
Summenformel:
C17H13IN4
Molgewicht:
400.22
MOL-Datei:
1311465-22-1.mol

1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide Eigenschaften

Sicherheit

1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide Chemische Eigenschaften,Einsatz,Produktion Methoden

1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 8)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd
+86-18791163155 +86-13119157289
13119157289@163.com China 2972 58
Shanghai Anyinuo Biomedical Technology Co., Ltd. 021-34625901
420970979@qq.com China 5836 58
Henan Weitesi Chemical Technology Co. LTD 0371-0371-55135753 18003832934
2853979818@qq.com China 9995 58
Shaanxi Lihe Tongchuang Chemical Technology Co., Ltd 029-81116050 17782851193
168361757@qq.com China 963 58
Hefei Ruiluo New Material Technology Co., Ltd. 19567218739
1759672789@qq.com China 1304 58
Shaanxi Cuikang Pharmaceutical Technology Co., Ltd 18049165724 13186333400
cuichengbio@163.com China 2687 58
Shaoyuan Technology (Shanghai) Co., Ltd. 021-50795510 4000665055
sy-c6@accelachem.com China 10000 58
Nanjing Shizhou Biology Technology Co.,Ltd 17301488900
judy.xia@synzest.com China 12582 58

  • 1,3-Diphenyl-3-imidazo[4,5-b]pyrazinium Iodide
  • 1H-lmidazo[4,5-b]pyrazinium,1,3-diphenyl-,iodide
  • 1,3-Diphenyl-1H-imidazo[4,5-b]pyrazin-3-ium iodide
  • 1,3-diphenylimidazo[4,5-b]pyrazin-3-ium
  • 1311465-22-1
Copyright 2019 © ChemicalBook. All rights reserved